Consolidated Balance Sheets - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Current Assets:
Cash and cash equivalents	$ 76,076	$ 601,042
Investments - trading securities	412,752	446,050
Total Current Assets	488,828	1,047,092
Fixed assets - net	132,661	128,704
Notes Receivable Entrepreneurship Development	4,378,210	1,658,987
Long term Notes Receivable - related parties	102,000	300,000
Mortgage Notes Receivable - related parties	2,655,251	2,609,001
Long term Investments - related parties	2,069,389	1,846,564
Total assets	9,826,340	7,590,348
Current Liabilities:
Accrued expenses	800	800
Accrued interest
Marginal loan payable		23,664
Line of credit - related party, current portion
Total Current Liabilities	800	24,464
Long-Term Liabilities:
Notes payable - net of current portion	1,276,978	588,859
Line of credit - related party, net of current portion	4,747,906	4,747,906
Total Long-Term Liabilities	6,024,884	5,336,765
Total Liabilities	6,025,684	5,361,229
STOCKHOLDERS’ EQUITY
Preferred stock, $.001 par value, 1,000,000 shares authorized, 1 issued and outstanding as at and June 30,2022 and December 31, 2021 respectively
Common Stock, $0.001 par value, 200,000,000 shares authorized, 182,370,497 issued and outstanding as at June 30,2022 and December 31, 2021 respectively.	182,370	177,922
Additional paid in capital	19,206,627	19,211,075
Accumulated deficit	(15,588,341)	(17,159,878)
Total Stockholders’ Equity	3,800,656	2,229,119
Total Liabilities and Stockholders’ Equity	$ 9,826,340	$ 7,590,348